Aphria’s latest results highlight positive outlook for marijuana industry

Be at the forefront of cannabis and psychedelics science and innovation. Register by March 14 & Save $100 on tickets to The Emerald Conference by MJBiz Science, April 1-3 in San Diego.


(This story is part of MJBizDaily’s premium subscription service, Investor Intelligence.)

Recent skepticism of the cannabis sector may be overblown, especially for companies that are fully funded – as highlighted by Aphria’s latest quarterly results.

While the market seems to have expected a guidance cut at Aphria, the company instead reported inline revenue for its fiscal first quarter – with surprise slight profitability – and reiterated its fiscal 2020 and long-term guidance.

A turn in sentiment would also mean that equity funding may be more readily available for the sector.

Our analysts break down Aphria’s latest results on Investor Intelligence.